Health Education Programs

We believe the best way to manage the healthcare system (of which pharmaceuticals are a component) is by encouraging appropriate utilization of pharmaceutical products, which only works well if patients are well educated on topics that may affect their health. To accomplish this, Lilly has invested resources in the development of numerous educational programs in both the public and private sectors in the United States and abroad. We have taken this educational initiative one step further in the United States and have sought out and received Program Design Certification from the National Committee for Quality Assurance (NCQA) for one new and four existing disease management programs.

The latest addition to our family of programs is Tools that Empower™ Depression Care Management Program. It was developed by experts in major depressive disorder, including practicing psychiatrists and psychologists, clinical research experts, managed care medical directors, and mental health specialty physicians. The foundation of this resource is based upon the APA Standards of Care for major depressive disorder, the HEDIS® measure for Antidepressant Medication Management, and several other related, peer-reviewed articles. Tools that Empower™ Depression Care Management Program is designed to assist you in your disease management efforts with a program that can be implemented in its entirety or by selecting components to augment your existing interventions.

Our existing programs are as follows:

• Tools That Empower™: Diabetes Management Program. It is a robust diabetes disease management program that contains more than 20 best-in-class tools and resources for care managers and diabetes program directors. It is based upon the American Diabetes Association clinical practice recommendations and HEDIS® performance measure.
• HealthInsights for Women is a disease management program that targets women 30 years and older about disease risk factors, and inspires them to make behavior changes that can lead to better health. All patient materials are now available in both English and Spanish.
• Health Evaluator for Lilly Partners (HELP) is a comprehensive, interactive online resource for patients that is flexible, customizable and secure. Wellness and disease condition information encourages patients to be active and responsible participants in their own care.
• Expanding Views: Achieving more with ADHD reinforces the importance of providing follow-up care for patients with attention-deficit/hyperactivity disorder (ADHD) based upon the HEDIS® measure. Its resources and tools are designed to reach 3 important groups: healthcare providers, adults with ADHD, and parents of children and adolescents with ADHD.

NCQA certification is an indication that a DM Program has passed a rigorous review in a specific area, either program design, patient contact or disease management systems. According to the NCQA, certification standards are purposely set high to encourage organizations to continuously enhance their quality.

“Disease management offers tremendous promise for improving the care received by the chronically ill,” said Margaret E. O’Kane, president of NCQA. “By achieving NCQA DM Certification, an organization is showing that it is ready to provide specific services that can help fulfill that promise.”

Offering relevant, non-branded interventions that are based on the most recent clinical research and findings is one example of how Lilly seeks to meet the needs of patients.

NCQA has reviewed and certified Lilly’s Program Design capability. For complete details on the scope of this review, please visit here.

back to the top